Clinical experience with leucovorin and 5-fluorouracil.

Abstract:

:Two trials of leucovorin (LV) and 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer were done, both using a 3-day loading dose and then weekly doses to minimize toxicity. The first trial used LV administered by intravenous infusion with a constant dose of 5-FU 400 mg/m2, and the second trail used oral LV with increasing doses of 5-FU. In the first trail, 45 eligible patients (20 with and 25 without previous therapy) were treated. Toxicity usually consisted of diarrhea or weakness and was controlled by delaying or decreasing the 5-FU dose. Subjective responses occurred in 75% of patients but did not correlate with antineoplastic effect. Objective responses were seen in 36% and stabilization of disease in 31% of patients; these correlated with prolonged survival. Median survival was 8 months for patients with previous treatment and 10 for those without. Twelve-month survival was 32% and 40%, respectively. There was no correlation between the development of toxicity and response or survival. The second trial was conducted recently in cooperation with Duke University to determine toxicity and efficacy of oral LV with intravenous 5-FU before a randomized trial of this combination versus placebo with intravenous 5-FU. Eighteen patients were treated, and serum levels of folates were obtained on ten. First toxicity occurred at 5-FU doses ranging from 375 to 850 mg/m2, and consisted of diarrhea in nine, lethargy in seven, nausea/vomiting in four, dermatitis in four, conjunctivitis in two, hypersalivation in two, stomatitis in one, and profound granulocytopenia in one. Response rate was 35%, and stabilization was 35% with median survival of 14 months. Twelve-month survival was 56%.

journal_name

Cancer

journal_title

Cancer

authors

Laufman LR,Brenckman WD Jr,Stydnicki KA,Morgan ED,Collier M,Knick VB,Duch DS,Mullin R,Ferone R

doi

10.1002/1097-0142(19890315)63:6+<1031::aid-cncr282

subject

Has Abstract

pub_date

1989-03-15 00:00:00

pages

1031-5

issue

6 Suppl

eissn

0008-543X

issn

1097-0142

journal_volume

63

pub_type

杂志文章

相关文献

CANCER文献大全
  • Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial.

    abstract:BACKGROUND:Follow-through of a positive screening test is necessary to reap the potential benefits of cancer screening. Racial variation in follow-through diagnostic care may underlie a proportion of the known disparity in prostate cancer mortality. The authors used data from the screening arm of the Prostate, Lung, Co...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.28042

    authors: Barocas DA,Grubb R 3rd,Black A,Penson DF,Fowke JH,Andriole G,Crawford ED

    更新日期:2013-06-15 00:00:00

  • Consecutive lymphoma with monoclonal gammopathy in a married couple.

    abstract::Mixed cellularity Hodgkin's disease and diffuse non-Hodgkin's lymphoma, mixed cell type, occurred consecutively in a husband and wife. Both patients demonstrated monoclonal IgM gammopathies. The unusual nature and possible significance of these findings are discussed. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860115)57:2<277::aid-cncr28205

    authors: Offit K,Macris NT,Hellman G,Rotterdam HZ

    更新日期:1986-01-15 00:00:00

  • Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.

    abstract:BACKGROUND:The purpose of this study was to examine local definitive therapy for nonmetastatic breast cancer with the Patterns of Care Breast and Prostate Cancer (POCBP) study of the National Program of Cancer Registries (Centers for Disease Control and Prevention). METHODS:POCBP medical record data were re-abstracted...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29092

    authors: Anderson RT,Morris CR,Kimmick G,Trentham-Dietz A,Camacho F,Wu XC,Sabatino SA,Fleming ST,Lipscomb J

    更新日期:2015-03-01 00:00:00

  • Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.

    abstract:BACKGROUND:To assess the ability of [(18)F]fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET) to predict the viability of residual masses after chemotherapy in patients with metastatic nonseminomatous germ cell tumors (GCT), PET results were compared in a blinded analysis with computed tomography (CT) sca...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10494

    authors: Kollmannsberger C,Oechsle K,Dohmen BM,Pfannenberg A,Bares R,Claussen CD,Kanz L,Bokemeyer C

    更新日期:2002-05-01 00:00:00

  • Cyclophosphamide-induced hemorrhagic cystitis in children with leukemia.

    abstract::The records of 314 children with acute lymphocytic leukemia (ALL) were reviewed to determine the frequency, clinical and laboratory features; contributing factors; and prognosis of cyclophosphamide-induced hemorrhagic cystitis. Twenty-five well-documented cases of hemorrhagic cystitis were identified. While most of th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197511)36:5<1572::aid-cncr282036

    authors: Lawrence HJ,Simone J,Aur RJ

    更新日期:1975-11-01 00:00:00

  • Age-related differences in the quality of life of breast carcinoma patients after treatment.

    abstract:BACKGROUND:The objective of this study was to compare the quality of life (QOL) of younger (< or =50 years) versus older (>50 years) women on recent completion of treatment of breast carcinoma. METHODS:Data reported herein were obtained from a baseline assessment of 304 breast carcinoma patients. These patients were e...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Wenzel LB,Fairclough DL,Brady MJ,Cella D,Garrett KM,Kluhsman BC,Crane LA,Marcus AC

    更新日期:1999-11-01 00:00:00

  • Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.

    abstract:BACKGROUND:Reliable predictive biomarkers are required to address the challenge of disease recurrence after thyroid cancer surgery. For this study, the authors assessed the association of cellular-based and serum-based immunologic mediators with thyroid cancer recurrence. METHODS:Leukocyte subset counts and immune reg...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27937

    authors: Owonikoko TK,Hossain MS,Bhimani C,Chen Z,Kim S,Ramalingam SS,Sun SY,Shin DM,Waller EK,Khuri FR

    更新日期:2013-04-15 00:00:00

  • Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.

    abstract::Aziridinylbenzoquinone (AZQ) was studied in a Phase II protocol for persons with glioma of the central nervous system (CNS) recurrent or progressive after surgery and radiotherapy. Patients received AZQ, 30 mg/m2 intravenously every 3 weeks if previously untreated or 27.5 mg/m2 if previously exposed to cytotoxic drugs...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850915)56:6<1311::aid-cncr2820

    authors: Haid M,Khandekar JD,Christ M,Johnson CM,Miller SJ,Locker GY,Merrill JM,Reisel H,Hatfield A,Lanzotti V

    更新日期:1985-09-15 00:00:00

  • Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report.

    abstract::During the period from September, 1976 to June, 1979, 70 patients with locoregional or extensive epidermoid carcinoma of the esophagus were treated with the two-drug combination of cisplatin and bleomycin (DB). For the 43 patients with locoregional disease (LRD), DB was used prior to surgery and/or radiation therapy; ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19841201)54:11<2351::aid-cncr282

    authors: Coonley CJ,Bains M,Hilaris B,Chapman R,Kelsen DP

    更新日期:1984-12-01 00:00:00

  • Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.

    abstract:BACKGROUND:Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) are increasingly likely to have received a novel tyrosine kinase inhibitor (NTKI) after failing imatinib mesylate. It is unknown whether the use of these NTKIs before HSCT increases transplant-rel...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22778

    authors: Jabbour E,Cortes J,Kantarjian H,Giralt S,Andersson BS,Giles F,Shpall E,Kebriaei P,Champlin R,de Lima M

    更新日期:2007-07-15 00:00:00

  • Whole-body protein metabolism in cancer-bearing patients. Effect of total parenteral nutrition and associated serum insulin response.

    abstract::Aggressive nutritional support of the cancer patient undergoing treatment has become widespread standard practice. In order to evaluate the effect of total parenteral nutrition (TPN) on protein metabolism, 11 patients with localized squamous cell carcinoma of the distal esophagus were studied in the postabsorptive sta...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840315)53:6<1246::aid-cncr2820

    authors: Burt ME,Stein TP,Schwade JG,Brennan MF

    更新日期:1984-03-15 00:00:00

  • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update ana

    abstract:BACKGROUND:The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow-up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer, anastrozole was superior to tamoxifen in terms of disease-free survival (DFS), time to r...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/cncr.11745

    authors: Baum M,Buzdar A,Cuzick J,Forbes J,Houghton J,Howell A,Sahmoud T,ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group.

    更新日期:2003-11-01 00:00:00

  • Hepatitis B related childhood hepatocellular carcinoma. Childhood hepatic malignancies.

    abstract::The case of hepatocellular carcinoma (HCC) with foci of hepatoblastoma in a 7-year-old boy, the son of a hepatitis B surface antigen (HBsAg) carrier mother, is described. Twelve other malignant liver tumors in children were tumors in children were also reviewed for HBsAg and hepatitis B core antigen (HBcAg). Both were...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870801)60:3<414::aid-cncr28206

    authors: De Potter CR,Robberecht E,Laureys G,Cuvelier CA

    更新日期:1987-08-01 00:00:00

  • Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.

    abstract:BACKGROUND:Caveolin-1 plays a regulatory role in several signaling pathways. Recently caveolin-1 was identified as a metastasis-related gene in prostate carcinoma. However, the clinical impact of caveolin-1 expression in esophageal carcinoma remains unknown. METHODS:One hundred thirty surgical specimens of esophageal ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Kato K,Hida Y,Miyamoto M,Hashida H,Shinohara T,Itoh T,Okushiba S,Kondo S,Katoh H

    更新日期:2002-02-15 00:00:00

  • Immunochemotherapy in human lung cancer using the streptococcal agent OK-432.

    abstract::Streptococcal agent OK-432 was administered at maintenance levels with conventional inductive chemotherapeutic agents to stage III and IV lung cancer patients. Survival rates were longer in patients treated with OK-432 than in patients treated without OK-432. An enhancement of lymphocyte blastogenic activity and a del...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197605)37:5<2201::aid-cncr282037

    authors: Kimura I,Ohnoshi T,Yasuhara S,Sugiyama M,Urabe Y

    更新日期:1976-05-01 00:00:00

  • Malignant inflammatory histiocytoma (inflammatory fibrous histiocytoma): report of a patient with four lesions.

    abstract::A patient with four subcutaneous inflammatory fibrous histiocytomas is presented. Three of these tumors developed synchronously. The neoplasms were examined by light and electron microscopy and were composed of well differentiated histiocytes, multinucleated histiocytes, and less differentiated cells. The ultrastructu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800101)45:1<179::aid-cncr28204

    authors: Miller R,Kreutner A Jr,Kurtz SM

    更新日期:1980-01-01 00:00:00

  • Intramedullary hemangioblastoma of the spinal cord: definitive management with irradiation.

    abstract::A young woman with a very extensive intramedullary hemangioblastoma of the spinal cord was treated with a moderately high dose of irradiation after biopsy only of the tumor. Now, five years following treatment, there have been no radiation sequelae and no evidence of progressive disease. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800101)45:1<49::aid-cncr282045

    authors: Richardson RG,Griffin TW,Parker RG

    更新日期:1980-01-01 00:00:00

  • The treatment of lymphoblastic lymphoma with antithymocyte globulin.

    abstract::A 20-year-old man with previously treated lymphoblastic lymphoma, a known T-cell disorder, developed progressive disease despite intensive combination chemotherapy with doxorubicin, vincristine, and prednisone. He was subsequently treated with a 21-day course of intravenous antithymocyte globulin at a dose of approxim...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820701)50:1<57::aid-cncr282050

    authors: Wong KK Jr,Sweet DL,Variakojis D

    更新日期:1982-07-01 00:00:00

  • Wide excision without radiation for desmoplastic melanoma.

    abstract:BACKGROUND:Adjuvant radiation has been proposed for the treatment of patients with desmoplastic melanoma, who reportedly have local recurrence rates as high as 40-60%. The authors investigated local recurrence rates at a tertiary referral center to determine the success of wide excision alone for patients with desmopla...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21311

    authors: Arora A,Lowe L,Su L,Rees R,Bradford C,Cimmino VC,Chang AE,Johnson TM,Sabel MS

    更新日期:2005-10-01 00:00:00

  • The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study.

    abstract:BACKGROUND:The high recurrence rate of hepatocellular carcinoma (HCC) determines the long-term prognosis for patients with HCC. In the current study, the authors tested the effects of menatetrenone, a vitamin K2 analog, on recurrent HCC and survival after curative treatment. METHODS:Sixty-one patients who were diagnos...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.21667

    authors: Mizuta T,Ozaki I,Eguchi Y,Yasutake T,Kawazoe S,Fujimoto K,Yamamoto K

    更新日期:2006-02-15 00:00:00

  • Environmental factors in cancer of the larynx: a second look.

    abstract::During a retrospective case-control study of recent laryngeal cancer patients, several associated factors were studied to determine possible changes in the epidemiology of laryngeal cancer between 1956 and 1974. The large sex difference noted in the early survey (male: female ratio of 14.9:1) diminished considerably i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197610)38:4<1591::aid-cncr282038

    authors: Wynder EL,Covey LS,Mabuchi K,Mushinski M

    更新日期:1976-10-01 00:00:00

  • A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children.

    abstract:BACKGROUND:Poor enrollment of adolescents and young adults (AYAs) (ages 15-39 years) onto cancer clinical trials (CCTs) may contribute to inferior survival gains compared with children. In this study, the authors assessed whether differences in CCT availability would explain lower CCT enrollment for early AYAs (eAYAs) ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31127

    authors: Thomas SM,Malvar J,Tran H,Shows J,Freyer DR

    更新日期:2018-03-01 00:00:00

  • Apical lung carcinoma.

    abstract::During the period 1955 to 1975, 63 consecutive cases of apical lung carcinoma were treated in the Radiation Therapy Division of the University of Michigan Medical Center (UMMC). Supervoltage external radiation alone or combination of radiation and surgery were the main modalities of treatment used in these patients. O...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840901)54:5<913::aid-cncr28205

    authors: Ahmad K,Fayos JV,Kirsh MM

    更新日期:1984-09-01 00:00:00

  • Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reaction.

    abstract::The authors retrospectively searched for human papillomavirus (HPV) types 16 and 18 in 60 cases of carcinoma arising from the nasal cavities (NC) and paranasal sinuses (PS) by using the polymerase chain reaction (PCR) on DNA extracted from formalin-fixed, paraffin-embedded tissues. In cases of SCC (n = 49), the author...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920115)69:2<353::aid-cncr28206

    authors: Furuta Y,Takasu T,Asai T,Shinohara T,Sawa H,Nagashima K,Inuyama Y

    更新日期:1992-01-15 00:00:00

  • Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

    abstract::A series of consecutive trials were undertaken to determine whether higher doses of intravenous metoclopramide and combinations of metoclopramide, dexamethasone, and diphenhydramine would improve antiemetic control or decrease treatment-related side effects in patients receiving cisplatin at 120 mg/m2. Metoclopramide ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19850201)55:3<527::aid-cncr28205

    authors: Kris MG,Gralla RJ,Tyson LB,Clark RA,Kelsen DP,Reilly LK,Groshen S,Bosl GJ,Kalman LA

    更新日期:1985-02-01 00:00:00

  • Small bore catheter drainage and sclerotherapy for malignant pleural effusions.

    abstract::The accumulation of large amounts of fluid in the pleural space is a common sequela of disseminated carcinomatosis. Traditional management has included therapeutic thoracentesis or the placement of a large bore chest tube for drainage with the subsequent installation of a sclerosing agent in an attempt to achieve pleu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890915)64:6<1218::aid-cncr2820

    authors: Parker LA,Charnock GC,Delany DJ

    更新日期:1989-09-15 00:00:00

  • The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes C colorectal cancer.

    abstract::This study examines the interrelationships of depth of penetration, tumor size, and the number of positive nodes in Dukes C colorectal cancer. The results indicated that depth of tumor penetration was related to both tumor size and the number of positive regional lymph nodes. Tumors with positive nodes which failed to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840615)53:12<2707::aid-cncr282

    authors: Wolmark N,Fisher ER,Wieand HS,Fisher B

    更新日期:1984-06-15 00:00:00

  • Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experience.

    abstract::Thirteen patients with regional or distant metastases from Merkel cell carcinoma were treated with combination chemotherapy. Three patients had a complete response to therapy. In two patients with nodal disease the duration of response was 10+ and 4+ years. In addition, three patients had a partial response, and six p...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19880815)62:4<683::aid-cncr28206

    authors: Feun LG,Savaraj N,Legha SS,Silva EG,Benjamin RS,Burgess MA

    更新日期:1988-08-15 00:00:00

  • Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.

    abstract:BACKGROUND:Children with average-risk acute lymphoblastic leukemia (AR-ALL) face many challenges that can adversely affect their quality of life (QOL). However, to the authors' knowledge, patterns and predictors of QOL impairment during therapy have not been well characterized to date. METHODS:Patients with AR-ALL who...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31085

    authors: Zheng DJ,Lu X,Schore RJ,Balsamo L,Devidas M,Winick NJ,Raetz EA,Loh ML,Carroll WL,Sung L,Hunger SP,Angiolillo AL,Kadan-Lottick NS

    更新日期:2018-02-01 00:00:00

  • 9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.

    abstract:BACKGROUND:9-Aminocamptothecin (9AC) and its parent compound, camptothecin, have shown outstanding preclinical activity against colorectal carcinoma. Irinotecan (CPT-11), another camptothecin derivative, has demonstrated clinical activity in patients with 5-fluorouracil (5-FU)-refractory colorectal carcinoma. METHODS:...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(sici)1097-0142(19971101)80:9<1727::aid-cn

    authors: Saltz LB,Kemeny NE,Tong W,Harrison J,Berkery R,Kelsen DP

    更新日期:1997-11-01 00:00:00